After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care - Takeaways - MDSpire

After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care

  • By

  • Anna Zucker

  • May 28, 2026

  • 0 min

Share

  • 1

    Telehealth platforms have improved access to GLP-1 medications for obesity, facilitating faster prescriptions but leaving some financial barriers.

  • 2

    Patients using telehealth for GLP-1 medications may experience muscle loss and micronutrient deficiencies due to insufficient clinical support.

  • 3

    Integrating registered dietitians into telehealth programs can enhance patient outcomes by promoting sustainable lifestyle changes.

  • 4

    Research indicates that a significant portion of weight loss during GLP-1 therapy may come from lean tissue, raising health concerns.

  • 5

    The lack of ongoing clinical support in telehealth contrasts with traditional care, which typically involves interdisciplinary team management.

Original Source(s)

After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care

  • by Anna Zucker

  • May 28, 2026

Related Content

Metabolic and bariatric surgery in mild obesity: mid-term outcomes and safety in an Asian population

Side Effects: They Googled It

Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.

Epicardial fat area as an independent predictor of atrial fibrillation occurrence and severity